Odonate Therapeutics Inc

NASDAQ:ODT   3:59:54 PM EDT
2.99
-0.07 (-2.29%)
Products, Regulatory

Positive Results Of Contessa, A Phase 3 Study Of Tesetaxel In Patients With Metastatic Breast Cancer, Presented At The 2020 San Antonio Breast Cancer Symposium (Sabcs)

Published: 12/11/2020 17:17 GMT
Odonate Therapeutics Inc (ODT) - Positive Results of Contessa, a Phase 3 Study of Tesetaxel in Patients With Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (sabcs).
Odonate Therapeutics Inc - Plan to Submit a New Drug Application for Tesetaxel to FDA in Mid‑2021.
Odonate Therapeutics Inc - Contessa Met Primary Endpoint of Improved Pfs As Assessed by Irc.